Mironid® Limited

Mironid® Limited company information, Employees & Contact Information

Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. This allows us to access multiple therapeutic areas for exploitation. Our lead programme is in the area of rare genetic kidney disease.

Company Details

Employees
17
Founded
-
Address
Arbuthnott Building (Hamnett Wing), 161 Cathedral Street, Glasgow,g4 0re,united Kingdom
Email
en****@****nid.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Glasgow
Looking for a particular Mironid® Limited employee's phone or email?

Mironid® Limited Questions

News

Activation of Phosphodiesterase 3A: New Hope for Cardioprotection - American Heart Association Journals

Activation of Phosphodiesterase 3A: New Hope for Cardioprotection American Heart Association Journals

Bridging science and technology: a biotech CEO’s perspective - Drug Target Review

Bridging science and technology: a biotech CEO’s perspective Drug Target Review

Mironid’s potential first-in-class candidate slows renal disease progression - BioWorld MedTech

Mironid’s potential first-in-class candidate slows renal disease progression BioWorld MedTech

Mironid On Reducing The Burden Of Polycystic Kidney Disease - Citeline News & Insights

Mironid On Reducing The Burden Of Polycystic Kidney Disease Citeline News & Insights

Mironid - The Pharma Letter

Mironid The Pharma Letter

U.K.’s Mironid closes $6.2M Series A for cancer, kidney disease projects - Fierce Biotech

U.K.’s Mironid closes $6.2M Series A for cancer, kidney disease projects Fierce Biotech

University spin-out raises £35M to develop treatment for life-threatening kidney disease - strath.ac.uk

University spin-out raises £35M to develop treatment for life-threatening kidney disease strath.ac.uk

New drug compound could tackle major life-limiting kidney disease ADPKD - Kidney Research UK

New drug compound could tackle major life-limiting kidney disease ADPKD Kidney Research UK

New drug compound could treat polycystic kidney disease - Medical Dialogues

New drug compound could treat polycystic kidney disease Medical Dialogues

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant